Prime Medicine, Inc. (Nasdaq: PRME), a biotechnology company committed to delivering a new class of differentiated one-time curative genetic therapies, today announced the appointment of Matthew ...
Hormel ( HRL) warned that it continued to experience persistent inflation in key commodity inputs at levels exceeding ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback